Literature DB >> 9129205

Wherefore interferon?

I Gresser1.   

Abstract

Interferon (IFN) was discovered by virologists interested in the phenomenon of viral interference and for many years was considered to be exclusively an antiviral substance. In time, it was accepted that the antiviral action was only one manifestation of the multiple effects of IFN on cells. IFN was shown to inhibit the development of tumors, to modulate immune function, and even to induce disease. Some aspects of these phenomena will be discussed. Despite this plethora of biological effects of type I IFN, the potency of its antiviral action, combined with its varied effects on both the cell-mediated and humoral immune response, render it a most effective and remarkable antiviral substance. Arguments will be presented to support the hypothesis that the major role of IFN is, after all, in antiviral defense. Finally, the use of type I IFN in the treatment of patients with viral and neoplastic diseases and even diseases of varied and unknown etiology is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129205     DOI: 10.1002/jlb.61.5.567

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  19 in total

1.  Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication.

Authors:  Karen L Mossman; James R Smiley
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism.

Authors:  K D Ryman; W B Klimstra; K B Nguyen; C A Biron; R E Johnston
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Herpes simplex virus ICP0 mutants are hypersensitive to interferon.

Authors:  K L Mossman; H A Saffran; J R Smiley
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Possible involvement of the double-stranded RNA-binding core protein sigmaA in the resistance of avian reovirus to interferon.

Authors:  J Martínez-Costas; C González-López; V N Vakharia; J Benavente
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Molecular characterization and expression of type-I interferon gene in Labeo rohita.

Authors:  Janmejay Parhi; S C Mukherjee; Gopalkrishna Saxena; Lopamudra Sahoo; M Makesh
Journal:  Mol Biol Rep       Date:  2014-01-22       Impact factor: 2.316

Review 6.  Inborn errors of anti-viral interferon immunity in humans.

Authors:  Vanessa Sancho-Shimizu; Rebeca Perez de Diego; Emmanuelle Jouanguy; Shen-Ying Zhang; Jean-Laurent Casanova
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

7.  Effect of 3 growth control substances on foreign body sarcomagenesis: IFN, IUdR, MGBG.

Authors:  M Mhic Iomhair; S M Lavelle
Journal:  Ir J Med Sci       Date:  1999 Jan-Mar       Impact factor: 1.568

8.  IFN-alpha acts on T-cell receptor-triggered human peripheral leukocytes to up-regulate CCR5 expression on CD4+ and CD8+ T cells.

Authors:  Y F Yang; M Tomura; M Iwasaki; S Ono; J P Zou; K Uno; G M Shearer; H Fujiwara; T Hamaoka
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

9.  Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

10.  Molecular and functional analysis of an interferon gene from the zebrafish, Danio rerio.

Authors:  Stephen M Altmann; Mark T Mellon; Daniel L Distel; Carol H Kim
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.